Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19513299 | 0.74 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL19513297 | 0.74 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL4105587 | 0.73 | MC4R (0.36) | CYP3A4ACHEATMNR1H4EPAS1 | |
| SCHEMBL24498650 | 0.72 | ALDH1A1 (0.31) | CYP3A4ALDH1A1CYP2C9TSHRCYP2C19 | |
| SCHEMBL9883158 | 0.71 | ALDH1A1 (0.35) | CYP3A4PTPN1ALDH1A1CYP2C9TSHR | |
| SCHEMBL15874511 | 0.71 | ALDH1A1 (0.35) | CYP3A4PTPN1ALDH1A1CYP2C9TSHR | |
| SCHEMBL1928919 | 0.69 | — | — | |
| SCHEMBL8994736 | 0.69 | CYP3A4 (0.40) | CYP3A4ACHEALOX15TP53PTPN2 | |
| SCHEMBL1427712 | 0.69 | CYP3A4 (0.40) | CYP3A4ACHEALOX15TP53PTPN2 | |
| SCHEMBL584183 | 0.69 | CYP1A2 (0.35) | CYP3A4PTPN2PTPN1ALDH1A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 846 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SYMRISE AG (DE) | 2020-12-29 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| WO-2020015880-A1 | BI-PHASE DEODORIZING COSMETIC COMPOSITION | BEIERSDORF AG (DE) | 2020-01-23 | — | — | WO | claimed |
| EP-3423028-A1 | METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY | Symrise AG (DE) | 2019-01-09 | — | — | EP | claimed |
| US-12630781-B2 | Fragrance or flavour mixture | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | SYMRISE AG (DE) | 2026-05-12 | — | — | US | disclosed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4731617-A1 | USE OF DIHYDROPYRAN DERIVATIVES AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4728447-A1 | ENVIRONMENTAL ATTRIBUTES FOR AROMA CHEMICAL | BASF SE (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4724434-A1 | AMBERGRIS ISOMERS AND MIXTURES THEREOF | Symrise AG (DE) | 2026-04-15 | — | — | EP | disclosed |
| US-20020111519-A1 | Process for the preparation of isolongifolanol | SYMRISE GMBH & CO. KG (DE) | 2002-08-15 | — | — | US | disclosed |
| US-20020111280-A1 | Care agents | SYMRISE AG (DE) | 2002-08-15 | — | — | US | disclosed |
| US-6420334-B1 | 2-ALKOXYDECAHYDRO-2,3A,4,4,7-PENTAMETHYL-3,7A-METHANO-7AH-INDENO(5,6-B)FURANS; ETHERIFICATION AND CYCLIZATION OF HYDROXY KETONE OR ENOL ETHER WITH AN ALCOHOL; FRAGRANCES; PERFUMES; STABILE; EFFECTIVE; LONG-LASTING | HAARMANN & REIMER GMBH (DE) | 2002-07-16 | — | — | US | disclosed |
| US-20020077258-A1 | Multiphase soaps | HAARMANN & REIMER GMBH (DE) | 2002-06-20 | — | — | US | disclosed |
| US-20020055453-A1 | Novel macrocyclic ketones | SYMRISE GMBH & CO. KG (DE) | 2002-05-09 | — | — | US | disclosed |
| US-20010005711-A1 | Perfume compositions comprising 4,8-dimethyl-3,7-nonadien-2-one | SYMRISE GMBH & CO. KG (DE) | 2001-06-28 | — | — | US | disclosed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010005711-A1 | Perfume compositions comprising 4,8-dimethyl-3,7-nonadien-2-one | DEK, DPM1, DEGS1 | CYP3A4 289/4885ACHE 2088/4885ATM 3320/4885 |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | TAS2R7, TAS2R42, TAS2R39 | CYP3A4 2442/4885ACHE 48/4885ATM 1673/4885 |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SMOX, LIPA, SGMS2 | CYP3A4 1233/4885ACHE 52/4885ATM 2538/4885 |
| US-12630781-B2 | Fragrance or flavour mixture | NOTUM, FFAR2, FFAR1 | CYP3A4 1721/4885ACHE 619/4885ATM 1622/4885 |
| US-20020055453-A1 | Novel macrocyclic ketones | FASN, KCNK5, NOTUM | CYP3A4 56/4885ACHE 643/4885ATM 4117/4885 |
| US-20020111519-A1 | Process for the preparation of isolongifolanol | UGT1A6, UMPS, UGT1A7 | CYP3A4 167/4885ACHE 2687/4885ATM 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.